US Bancorp’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-111
| Closed | -$1K | – | 4193 |
|
|
2021
Q2 | $1K | Hold |
111
| – | – | ﹤0.01% | 3960 |
|
|
2021
Q1 | $1K | Hold |
111
| – | – | ﹤0.01% | 3845 |
|
|
2020
Q4 | $4K | Sell |
111
-249
| -69% | -$4.29K | ﹤0.01% | 3467 |
|
|
2020
Q3 | $5K | Hold |
360
| – | – | ﹤0.01% | 3323 |
|
|
2020
Q2 | $6K | Hold |
360
| – | – | ﹤0.01% | 3276 |
|
|
2020
Q1 | $3K | Hold |
360
| – | – | ﹤0.01% | 3409 |
|
|
2019
Q4 | $8K | Hold |
360
| – | – | ﹤0.01% | 3177 |
|
|
2019
Q3 | $5K | Hold |
360
| – | – | ﹤0.01% | 3259 |
|
|
2019
Q2 | $5K | Hold |
360
| – | – | ﹤0.01% | 3299 |
|
|
2019
Q1 | $6K | Hold |
360
| – | – | ﹤0.01% | 3216 |
|
|
2018
Q4 | $5K | Hold |
360
| – | – | ﹤0.01% | 3230 |
|
|
2018
Q3 | $8K | Hold |
360
| – | – | ﹤0.01% | 3212 |
|
|
2018
Q2 | $15K | Hold |
360
| – | – | ﹤0.01% | 3032 |
|
|
2018
Q1 | $24K | Hold |
360
| – | – | ﹤0.01% | 2895 |
|
|
2017
Q4 | $26K | Hold |
360
| – | – | ﹤0.01% | 2846 |
|
|
2017
Q3 | $33K | Hold |
360
| – | – | ﹤0.01% | 2735 |
|
|
2017
Q2 | $24K | Sell |
360
-14
| -4% | -$1.73K | ﹤0.01% | 2831 |
|
|
2017
Q1 | $82K | Buy |
374
+14
| +4% | +$2K | ﹤0.01% | 2243 |
|
|
2016
Q4 | $33K | Sell |
360
-32
| -8% | -$3.61K | ﹤0.01% | 2657 |
|
|
2016
Q3 | $53K | Hold |
392
| – | – | ﹤0.01% | 2413 |
|
|
2016
Q2 | $40K | Hold |
392
| – | – | ﹤0.01% | 2513 |
|
|
2016
Q1 | $64K | Buy |
392
+32
| +9% | +$6.49K | ﹤0.01% | 2259 |
|
|
2015
Q4 | $118K | Hold |
360
| – | – | ﹤0.01% | 1975 |
|
|
2015
Q3 | $116K | Hold |
360
| – | – | ﹤0.01% | 1999 |
|
|
2015
Q2 | $144K | Hold |
360
| – | – | ﹤0.01% | 1929 |
|
|
2015
Q1 | $177K | Hold |
360
| – | – | ﹤0.01% | 1847 |
|
|
2014
Q4 | $129K | Hold |
360
| – | – | ﹤0.01% | 1986 |
|
|
2014
Q3 | $69K | Buy |
360
+249
| +224% | +$54.7K | ﹤0.01% | 2314 |
|
|
2014
Q2 | $27K | Hold |
111
| – | – | ﹤0.01% | 2747 |
|
|
2014
Q1 | $28K | Hold |
111
| – | – | ﹤0.01% | 2712 |
|
|
2013
Q4 | $22K | Hold |
111
| – | – | ﹤0.01% | 2743 |
|
|
2013
Q3 | $19K | Hold |
111
| – | – | ﹤0.01% | 2692 |
|
|
2013
Q2 | $20K | Buy |
+111
| New | +$15.7K | ﹤0.01% | 2668 |
|
Other funds holding LUMO
NMC
LPC
JG
BCM
US Bancorp's LUMO Position: Q3 2021 in Review
US Bancorp sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q3 2021, closing a stake of 111 shares — an estimated $1K sold.
US Bancorp first reported a position in LUMO in Q2 2013 and held it in 33 quarters. The position peaked at $177K in Q1 2015. 37 funds tracked by Wall St. Rank hold LUMO as of Q3 2021.
- US Bancorp reported no remaining Lumos Pharma, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
- US Bancorp sold 111 Lumos Pharma, Inc. Common Stock shares in Q3 2021, an estimated $1K.
- US Bancorp first reported a position in Lumos Pharma, Inc. Common Stock in Q2 2013 and held it in 33 quarters.
- US Bancorp's Lumos Pharma, Inc. Common Stock position peaked at $177K in Q1 2015.
- 37 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q3 2021.
Based on US Bancorp's 13F filing for Q3 2021, filed 10 Nov 2021.